|
| Date |
Time |
Place |
Session / Title |
Role |
|
| April 28 |
9:08 AM - 9:16 AM |
Coronary Theater, Level 1 |
Left Main & Bifurcation PCI I. Left Main PCI
Unprotected Left Main Coronary Disease: Thoughtful Insights |
Lecturer |
| April 29 |
7:00 AM - 8:00 AM |
Coronary Theater, Level 1 |
Bioresorbable Vascular Scaffolds |
Moderator |
| April 29 |
7:30 AM - 7:40 AM |
Coronary Theater, Level 1 |
Bioresorbable Vascular Scaffolds
Unrestricted Adoption in Real World Patients Is Possible. |
Lecturer |
| April 29 |
8:40 AM - 9:10 AM |
Interview Lounge, Level 2 |
BVS (Bioresorbable Vascular Scaffold) for Coronary Artery Disease |
Moderator |
| April 29 |
11:00 AM - 11:45 AM |
Main Arena, Level 3 |
TCT @ TCTAP 2015: Controversies and Hot Topics |
Moderator |
| April 29 |
11:00 AM - 11:10 AM |
Main Arena, Level 3 |
TCT @ TCTAP 2015: Controversies and Hot Topics
New Metallic DES: Bioresorbable Polymers or Polymer-Free |
Lecturer |
| April 29 |
12:45 PM - 1:45 PM |
Coronary Theater, Level 1 |
The 4th Revolution in PCI (Bioresorbable Vascular Scaffolds) |
Moderator |
| April 29 |
2:40 PM - 2:48 PM |
Room 104, Level 1 |
Imaging & Physiology Summit
Serial Follow-up Imaging of Bioresorbable Vascular Scaffolds and Clinical Implication |
Lecturer |
| April 29 |
3:12 PM - 3:24 PM |
Coronary Theater, Level 1 |
Coronary Session I
Theoretical Construct: Why BRS May Change the Landscape of Coronary Intervention? |
Lecturer |
| April 29 |
3:40 PM - 4:10 PM |
Interview Lounge, Level 2 |
CABG vs. PCI for LM or 3VD |
Interviewee |
| April 29 |
4:30 PM - 6:00 PM |
Room 104, Level 1 |
DES & BVS |
Moderator |
| April 29 |
5:24 PM - 5:32 PM |
Room 104, Level 1 |
DES & BVS
Future of BRS |
Lecturer |
| April 29 |
5:38 PM - 5:46 PM |
Room 104, Level 1 |
DES & BVS
Yes, It Can Replace Metal Stent. |
Lecturer |
| April 29 |
6:00 PM - 8:00 PM |
Room 104, Level 1 |
Risk Awareness of Secondary Events in Post MI Patients and Secondary Prevention |
Moderator |
| April 29 |
6:05 PM - 6:10 PM |
Room 104, Level 1 |
Risk Awareness of Secondary Events in Post MI Patients and Secondary Prevention
Opening Remark (2) |
Speaker |
| April 30 |
7:00 AM - 8:10 AM |
Room 104, Level 1 |
New Horizon for Aortic Valve Treatment |
Panelist |
| April 30 |
7:50 AM - 7:58 AM |
Room 104, Level 1 |
New Horizon for Aortic Valve Treatment
SURTAVI: Transaortic Valve Replacement Compared to Surgical Aortic Valve Replacement in Medium-Risk Patients |
Lecturer |
| April 30 |
9:30 AM - 10:54 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Moderator |
| April 30 |
10:20 AM - 10:26 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Discussant |
| April 30 |
10:48 AM - 10:54 AM |
Coronary Theater, Level 1 |
Coronary Session III. Late Breaking Clinical Trials & Leading Clinical Trials from Asan Medical Center |
Discussant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
